Article · 19 Feb 2026
ArticlePublished 2018
Complex Ã?ŽÃ?±-Lypoic Acid, Ginkgoselect Phytosome and Leucoselect Phytosome in Patients with Chronic Venous Insufficiency of the Lower Limbs: Therapeutic Effectiveness and Impact on Quality of Life
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Chronic venous disease (CVD) is a common clinical condition, especially relevant for its impact on public health and its related economic burden. Veno-Active Drugs (VAD) are an heterogeneous group of drugs, widely used in the treatment of CVD. In the last years some food supplements, similar to VAD but with different compounds concentrations raised some confusion in this field. The complex Lypoic acid, Ginkgoselect phytosome and Leucoselect phytosome is a food supplement based on molecules exhibiting different but synergic activities never prospectively tested in patients with CVD. Methods: Consecutive ambulatory patients with objectively documented CVD and a CEAP “C” up to 5 were eligible for the study. Patients were to take 1 fast-slow tablet of the complex twice-daily for 2 months, followed by 1 fast-slow tablet once-daily for other 4 months, for a total of 6 months. Presence and magnitude of CVD-related signs and symptoms (with “C” of the CEAP classification), evaluation of patients’ quality of life (with VEINES-QoL/Sym questionnaire) and assessment of safety and tolerability of the complex at baseline and after 2 and 6 months (with revised Venous Clinical Severity Score, rVCSS) were recorded. Results: 97 patients enrolled and evaluated. The proportion (65%) of the patients with a rVCSS score>5 at baseline decreased to 35% at 6 months (P <0.001). The number of patients with a scoring of “none” for the item “Pain or other discomfort” increased from 8% at baseline to 54% at 6 months (P=0.001). The pairwise comparison yielded significant results between the 3 time-points for the rVCSS (p<0.00001) and the VEINES-Sym (p<0.00001), while for the VEINES-QoL score between the baseline and the end of the study only (p=0.0016). Conclusion: The complex Lypoic acid, Ginkgoselect phytosome and Leucoselect phytosome seems beneficial for reducing leg complaints, and effectively improves QoL in patients with CVD.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Blood & Lymph.
Commentary · 1 Jan 2026
Commentary on Prosthetic Valve Dysfunction Post-Bevacizumab: A TAVR Thrombosis
Commentary · 1 Jan 2026
The Interaction of Blood and Lymphatic Systems: Insights for Modern Hemato-Lymphatic Research
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood & Lymph
- SubjectHaematology
- BylineArticles whose byline prints “Giuseppe Camporese”
- BylineArticles whose byline prints “Enrico Bernardi”
- BylineArticles whose byline prints “Cristiano Bortoluzzi”
- BylineArticles whose byline prints “Dimitrios Kontothanassis”
- BylineArticles whose byline prints “Chiara Tonello”
- BylineArticles whose byline prints “Michela Nardin”
- BylineArticles whose byline prints “Franco Noventa”
